Price $40.37 |
Market Cap
8.74B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
47.4
|
P/B
3.3
|
P/S
5.72
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
36.8
|
Op. Cash Flow
356K
|
FCF
1.0
|
|
Op. Margin
17.20%
|
Net Margin
12.40%
|
ROE
7.30%
|
ROI
4.80%
|
|
ROA
3.40%
|
EPS Growth
243.40%
|
Current Ratio
2.2
|
Debt/Equity
63.40%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Cesca Therapeutics Inc (KOOL) | $2.71 | - | - | 6.1M | Strong Buy |
| Harvard Bioscience, Inc. (HBIO) | $1.99 | - | - | 87.4M | Strong Buy |
| Hologic, Inc. (HOLX) | $48.33 | - | - | 11.78B | Strong Buy |
| PDL BioPharma Inc (PDLI) | $3.08 | - | - | 355.9M | Strong Buy |
| ImmuCell Corporation (ICCC) | $6.50 | - | - | 44.5M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
